Pumactant and poractant alfa for treatment of respiratory distress syndrome in neonates born at 25–29 weeks' gestation: a randomised trial

This publication has 28 references indexed in Scilit:

• Natural vs Synthetic Surfactants in Neonatal Respiratory Distress Syndrome
  Drugs, 1996
• Biophysical properties of protein-free, totally synthetic pulmonary surfactants, ALEC and Exosurf, in comparison with surfactant TA
  Pediatrics International, 1994
• Comparison of surface properties and physiological effects of a synthetic and a natural surfactant in preterm rabbits.
  Archives of Disease in Childhood: Fetal & Neonatal, 1994
• Static respiratory compliance in the newborn. III: Early changes after exogenous surfactant treatment.
  Archives of Disease in Childhood: Fetal & Neonatal, 1994
• Deficiency of Pulmonary Surfactant Protein B in Congenital Alveolar Proteinosis
  New England Journal of Medicine, 1993
• Randomized trial of artificial surfactant (ALEC) given at birth to babies from 23 to 34 weeks gestation
  Early Human Development, 1988
• TWO CONTROLLED TRIALS OF DRY ARTIFICIAL SURFACTANT: EARLY EFFECTS AND LATER OUTCOME IN BABIES WITH SURFACTANT DEFICIENCY
  The Lancet, 1985
• Effects of artificial surfactant on lung function and blood gases in idiopathic respiratory distress syndrome.
  Archives of Disease in Childhood, 1983
• Artificial surfactant and natural surfactant. Comparative study of the effects on premature rabbit lungs.
  Archives of Disease in Childhood, 1980
• Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gm
  The Journal of Pediatrics, 1978